Proficio Capital Partners LLC Takes $3.53 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Proficio Capital Partners LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 39,742 shares of the company's stock, valued at approximately $3,526,000. Proficio Capital Partners LLC owned 0.26% of U.S. Physical Therapy as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in USPH. Venturi Wealth Management LLC lifted its holdings in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV increased its position in U.S. Physical Therapy by 68.6% in the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock valued at $66,000 after acquiring an additional 315 shares in the last quarter. Pacer Advisors Inc. acquired a new stake in U.S. Physical Therapy in the 4th quarter valued at about $113,000. First Horizon Advisors Inc. increased its position in U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after acquiring an additional 298 shares in the last quarter. Finally, Mutual of America Capital Management LLC acquired a new stake in U.S. Physical Therapy in the 4th quarter valued at about $203,000.

Analyst Upgrades and Downgrades

USPH has been the subject of several research reports. Barrington Research lowered their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. JPMorgan Chase & Co. lowered their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, JMP Securities started coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an "outperform" rating and a $113.00 price target for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, U.S. Physical Therapy has an average rating of "Moderate Buy" and a consensus price target of $109.00.

Remove Ads

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Stock Down 2.9 %

Shares of USPH stock traded down $2.18 during trading on Friday, reaching $72.52. The company's stock had a trading volume of 268,706 shares, compared to its average volume of 99,668. The business has a fifty day moving average price of $84.85 and a 200-day moving average price of $86.99. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.10 billion, a price-to-earnings ratio of 77.14, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a one year low of $72.27 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date is Friday, March 14th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's payout ratio is currently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.